AVIDITY PARTNERS MANAGEMENT LP – Neurocrine Biosciences, Inc. Transaction History
AVIDITY PARTNERS MANAGEMENT LP portfolio value:
$197.09M
portfolio value
AVIDITY PARTNERS MANAGEMENT LP quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +26.44% | 388.1K shares | 54.03M | $106.21 | 1.85M |
| Q2 2022 | share | Increase | +26.52% | 307.6K shares | 34.31M | $97.48 | 1.46M |
| Q1 2022 | share | Decrease | -7.94% | -100K shares | 1.43M | $93.75 | 1.16M |
| Q4 2021 | share | Increase | +48.43% | 411.1K shares | 25.89M | $84.63 | 1.26M |
| Q3 2021 | share | Increase | +24.65% | 167.9K shares | 15.14M | $95.91 | 848.9K |
| Q2 2021 | share | Increase | +30.61% | 159.6K shares | 15.56M | $97.32 | 681K |
| Q1 2021 | share | Increase | +73.80% | 221.4K shares | 21.95M | $97.25 | 521.4K |
| Q4 2020 | share | Increase | 0.00% | 300K shares | 28.75M | $95.85 | 300K |
| Q3 2020 | share | Decrease | -100.00% | -185.1K shares | -22.58M | $96.16 | 0 |
| Q2 2020 | share | Increase | +88.88% | 87.1K shares | 14.1M | $122 | 185.1K |
| Q1 2020 | share | Increase | +196.97% | 65K shares | 4.93M | $86.55 | 98K |
| Q4 2019 | share | Increase | 0.00% | 33K shares | 3.54M | $107.49 | 33K |